Feed MYGN
MY
Myriad Genetics, Inc.
MYGN · NASDAQ
$3.03 -4.11% (-$0.13)
1M -48.82%
Market Cap $286.2M
P/E Ratio -
Div. Yield -
ROE 32.59%
Bulios Fair Price
$3.95
30.4% upside
Preț actual
$3.03
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile MYGN sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Valuation
44 /100
Fair P/S 0.35x
P/B 0.94x
P/FCF 58.40x
Growth
41 /100
Stable Rev. growth 6.72%
Book val. growth 25.38%
EPS growth N/A
Profitability
28 /100
Weak Gross margin 68.83%
Net margin 13.96%
Op. margin 4.03%
Quality
28 /100
Poor ROIC 6.35%
ROE 32.59%
ROA 17.62%
Debt
86 /100
Low Debt/Equity 0.69x
Current ratio 2.21x
Int. coverage 87.33x
Stability
36 /100
Moderate Beta 1.67x
Rev. volatility 7.32%
EPS volatility 124.28%
Întreabă StockBot despre MYGN
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Samraat S Raha
Employees
2,700
Headquarters
Salt Lake City
Evenimente viitoare
02 NOV.
Earnings
Upcoming earnings report